3
8. Antimicrobial
erapy
Clinicians should NOT routinely prescribe
antibiotics to treat dysphonia.
S-A against
9a. Laryngoscopy
Prior to Voice
erapy
Clinicians should perform diagnostic
laryngoscopy, or refer to a clinician who can
perform diagnostic laryngoscopy, before
prescribing voice therapy and document/
communicate the results to the speech-language
pathologist.
R-C
9b. Advocating for
Voice erapy
Clinicians should advocate voice therapy in
patients with dysphonia from a cause amenable to
voice therapy.
S-A
10. Surgery Clinicians should advocate for surgery as a
therapeutic option in patients with dysphonia
with conditions amenable to surgical intervention
such as suspected malignancy, symptomatic
benign vocal fold lesions that do not respond to
conservative management, or glottic insufficiency.
R-B
11. Botulinum Toxin Clinicians should offer, or refer to a clinician
who can offer, botulinum toxin injections for
the treatment of dysphonia caused by spasmodic
dysphonia and other types of laryngeal dystonia.
R-B
12. Education/
Prevention
Clinicians should inform patients with dysphonia
about control/preventive measures.
R-C
13. Outcomes Clinicians should document resolution,
improvement or worsened symptoms of
dysphonia, or change in quality of life in patients
with dysphonia aer treatment or observation.
R-C
Table 1. Summary of Guideline Key Action Statements (KAS)
(cont'd)
Statement Action Strength
